BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 18, 2002
View Archived Issues
Confirmatory Phase III Prestara Protocol Submitted By Genelabs
Genelabs Technologies Inc. has laid the groundwork for a confirmatory Phase III trial of its lupus drug, Prestara, and said it expects to begin the trial before the end of the year. (BioWorld Today)
Read More
NIH Awards Structural GenomiX Authority Over Protein Research
Read More
TransForm Pharmaceuticals, Weizmann Institute Align To Develop Better Malaria Drug
Read More
SuperGen Receives Approval For Supergeneric Mitozytrex
Read More
Medicon Valley Developing R&D Capabilities In Four Key Areas
Read More
ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer
Read More
Other News To Note
Read More